170 related articles for article (PubMed ID: 22772323)
1. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
2. Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome.
Jakiela B; Sanak M; Szczeklik W; Sokolowska B; Plutecka H; Mastalerz L; Musial J; Szczeklik A
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S23-34. PubMed ID: 21470488
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
4. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
5. Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome.
Saito H; Tsurikisawa N; Tsuburai T; Akiyama K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():73-6. PubMed ID: 18504411
[TBL] [Abstract][Full Text] [Related]
6. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17.
Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
Int Arch Allergy Immunol; 2009; 149 Suppl 1():61-5. PubMed ID: 19494507
[TBL] [Abstract][Full Text] [Related]
8. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome.
Szczeklik W; Sanak M; Mastalerz L; Sokołowska BM; Gielicz A; Soja J; Kumik J; Musiał J; Szczeklik A
Clin Exp Allergy; 2012 Apr; 42(4):513-22. PubMed ID: 22417211
[TBL] [Abstract][Full Text] [Related]
9. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
10. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome.
Dallos T; Heiland GR; Strehl J; Karonitsch T; Gross WL; Moosig F; Holl-Ulrich C; Distler JH; Manger B; Schett G; Zwerina J
Arthritis Rheum; 2010 Nov; 62(11):3496-503. PubMed ID: 20669282
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Churg-Strauss syndrome: recent insights.
Zwerina J; Axmann R; Jatzwauk M; Sahinbegovic E; Polzer K; Schett G
Autoimmunity; 2009 May; 42(4):376-9. PubMed ID: 19811306
[TBL] [Abstract][Full Text] [Related]
12. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
Bochner BS; Hudson SA; Xiao HQ; Liu MC
J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
[TBL] [Abstract][Full Text] [Related]
13. Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome.
Kiene M; Csernok E; Müller A; Metzler C; Trabandt A; Gross WL
Arthritis Rheum; 2001 Feb; 44(2):469-73. PubMed ID: 11229479
[TBL] [Abstract][Full Text] [Related]
14. Sputum eosinophilia in Churg-Strauss syndrome.
Meziane H; Maakel ML; Vachier I; Bousquet J; Chanez P
Respir Med; 2001 Oct; 95(10):799-801. PubMed ID: 11601744
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome.
Terrier B; Bièche I; Maisonobe T; Laurendeau I; Rosenzwajg M; Kahn JE; Diemert MC; Musset L; Vidaud M; Sène D; Costedoat-Chalumeau N; Le Thi-Huong D; Amoura Z; Klatzmann D; Cacoub P; Saadoun D
Blood; 2010 Nov; 116(22):4523-31. PubMed ID: 20729468
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome.
Tsukadaira A; Okubo Y; Kitano K; Horie S; Momose T; Takashi S; Suzuki J; Isobe M; Sekiguchi M
Allergy Asthma Proc; 1999; 20(1):39-44. PubMed ID: 10076708
[TBL] [Abstract][Full Text] [Related]
17. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
[TBL] [Abstract][Full Text] [Related]
18. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia.
Nureki S; Miyazaki E; Ando M; Kumamoto T; Tsuda T
Clin Immunol; 2005 Jul; 116(1):83-93. PubMed ID: 15925835
[TBL] [Abstract][Full Text] [Related]
19. Churg-Strauss syndrome: update on pathophysiology and treatment.
Vaglio A; Moosig F; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):24-30. PubMed ID: 22089097
[TBL] [Abstract][Full Text] [Related]
20. IL-5 expression and release from human CD34 cells in vitro; ex vivo evidence from cases of asthma and Churg-Strauss syndrome.
Bossios A; Sjöstrand M; Dahlborn AK; Samitas K; Malmhäll C; Gaga M; Lötvall J
Allergy; 2010 Jul; 65(7):831-9. PubMed ID: 19968630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
